Authors: Bugelski, PJ Herzyk, DJ Rehm, S Harmsen, AG Gore, EV Williams, DM Maleeff, BE Badger, AM Truneh, A O'Brien, SR Macia, RA Wier, PJ Morgan, DG Hart, TK

Citation: Pj. Bugelski et al., Preclinical development of keliximab, a Primatized (TM) anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model andsafety studies, HUM EXP TOX, 19(4), 2000, pp. 230-243